Proteomics Market Size, Growth Dynamics and Forecast to 2023

Market Overview:

The Global Proteomics Market is rising pervasively mainly due to the proliferating trend of personalized medicines. Proteomics is used in drug discovery and clinical diagnosis for a number of applications such as the investigation of protein expression, metabolic pathways, transcriptional & post-transcriptional studies, protein interaction in diseases, etc. Moreover, the burgeoning sectors such as healthcare and pharmaceutical escalate the market on the global platform.

Analyzing the ascending graph of the growth, the market is climbing steadily, Market Research Future (MRFR), in its recently published study report confirms that the global Proteomics Market Sizewill quadruple by 2023, registering a staggering double-digit CAGR over 14.1 % throughout the forecast period (2018 to 2023). In 2017, the market had accounted for a valuation of USD 23.2 BN.

Rising advances in proteomics research and new products launched in the proteomics market is anticipated to boost the growth of the market during the assessment period. In September 2017, Bruker introduced the timsTOF Pro system for parallel accumulation and serial fragmentation (PASEF) mass spectrometry, using proprietary trapped ion mobility spectrometry (TIMS) technology for higher-speed, higher-sensitivity and robust shotgun proteomics. On the other hand, high cost of equipment & tools and lack of skilled researchers may hinder the market growth during the forecast period.

Global Proteomics Market – Competitive Analysis

The widely expanded Proteomics market appears to be highly competitive with the presence of numerous large and small-scale players. These players compete against each other based on an array of services and pricing. Naturally, the competitive strength of these players is reliant on service pricing, service precision, versatility, and reliability of services. The market is forecasted to witness fierce competition with the potential extensions in innovations. Players operating in the Proteomics market strive to offer unique services with advanced features.

Focusing on rapid expansion and integration set for 2019-2019, these service providers build a company that can offer complementary services in key regions, in the emerging market.

While acquiring a company, they ensure to acquire a company with significant professional experience, state-of-the-art capabilities, and a long history of delivering high-quality pharmaceuticals that can meet or exceed customer expectations and regulatory requirements.

Major Players:

  • Bio-Rad Laboratories
  • General Electric Company
  • Danaher
  • Siemens Ltd
  • Agilent Technologies
  • Thermo Fisher Scientific Inc
  • Genzyme Corporation
  • Bruker
  • Biognosys AG
  • Luminex Corporation
  • PerkinElmer Inc

Global

Proteomics Market – Segments

For ease of understanding, the report is segmented into four key dynamics: -

By Equipment           : Chromatography, X-ray Crystallography, Protein Fractionation, Mass Spectroscopy, and Protein Microarray among others.

By Services               : Laboratory Services, and Data Analysis & Services among others.

By Application          : Drug Discovery and Clinical Diagnosis among others.

By Regions                : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Proteomics Market – Geographical Analysis

The global market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the global proteomics market owing to the rapid adoption of new technologies and investments in personalized medicines. According to a report published by the Personalized Medicine Coalition, the Food and Drug Administration approved a record number of 19 personalized medicines in 2017. It is the fourth consecutive year that personalized medicines accounted for more than 20 percent of all new drug approvals. The European region is anticipated to be the second largest due to the presence of a well-developed healthcare infrastructure and rising adoption of new technologies. The Asia-Pacific region is anticipated to be the fastest growing region due to the rising proteomics research. Middle East and Africa is anticpated to hold the least market share.